LC seemed slightly improved in the HCC group with 1- and 2-year-rates of 92% compared to the MD group with 1- and 2-year-rates of 89 and 64%, although this difference did not reach statistical significance.
← all excerpts
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.
1
—
—